查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1676283

全球醫院獲得性疾病檢測市場研究報告-產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Hospital Acquired Disease Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格

全球醫院獲得性疾病檢測市場規模預計將從 2024 年的 154.8 億美元成長到 2033 年的 663 億美元，在 2026 年至 2033 年的預測期內呈現 17.54% 的強勁年複合成長率(CAGR)。

受醫院內感染（HAI）發病率不斷上升以及對患者安全和護理品質日益重視的推動，醫院內疾病檢測市場將經歷強勁成長。隨著醫院和醫療機構努力降低醫院感染風險，對準確、快速的診斷檢測方法的需求變得至關重要。抗生素抗藥性病原體的增加進一步使情況複雜化，需要先進的檢測解決方案來快速識別感染的病原體並指導適當的治療策略。人們越來越意識到醫院感染對病患治療結果和醫療成本的影響，進而推動了市場的發展。

診斷測試技術的進步正在徹底改變醫院內感染疾病檢測市場。分子診斷、即時診斷和下一代定序等創新正在提高病原體檢測的速度和準確性。這些技術使醫療保健提供者能夠及時採取干涉措施，減少住院時間並改善患者的整體治療效果。此外，包括電子健康記錄和實驗室資訊系統在內的數位健康解決方案的整合正在簡化資料管理並促進醫療團隊之間的更好溝通，從而進一步提高感染控制措施的效率。

此外，醫院內感染檢測市場將受益於監管審查力度的加強和旨在減少醫院內感染的公共衛生措施。隨著醫療保健機構採用嚴格的感染預防協議，對全面檢測解決方案的需求將會上升。診斷公司、醫療保健提供者和監管機構之間的合作努力對於制定標準化測試指南和確保廣泛採用最佳實踐至關重要。隨著市場的發展，重點將轉向將檢測整合到更廣泛的感染控制策略中，強調監測、早期發現和有針對性的干涉在對抗醫院內感染疾病的重要性。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：醫院獲得性疾病檢測產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按測試類型進行市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球醫院獲得性疾病檢測市場分析：按檢測類型

  • 按測試類型概覽
  • 按測試類型進行的歷史和預測資料分析
  • 泌尿道感染
  • 手術部位感染
  • 肺炎支架
  • 血流感染
  • 抗甲氧西林金黃色葡萄球菌
  • 其他

第 6 章：全球醫院獲得性疾病檢測市場分析：按最終用戶

  • 最終用戶概覽
  • 最終用戶的歷史和預測數據分析
  • 醫院及重症加護病房 (ICUS)
  • 門診手術及診斷中心
  • 安養院及婦產中心
  • 公司

第 7 章：全球醫院獲得性疾病檢測市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 8 章：醫院獲得性疾病檢測公司的競爭格局

  • 醫院獲得性疾病檢測市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第9章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eurofins Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BIOMÉRIEUX
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cantel Medical
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Meridian Bioscience Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hologic Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Siemens Healthcare Private Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Medtronic
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Getinge AB
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11213861

Global Hospital Acquired Disease Testing Market size is anticipated to grow from USD 15.48 Billion in 2024 to USD 66.3 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.54% during the forecast period of 2026 to 2033.

The hospital-acquired disease testing market is set to experience robust growth, driven by the increasing incidence of healthcare-associated infections (HAIs) and the growing emphasis on patient safety and quality of care. As hospitals and healthcare facilities strive to minimize the risk of HAIs, the demand for accurate and rapid diagnostic testing methods is becoming paramount. The rise in antibiotic-resistant pathogens further complicates the landscape, necessitating advanced testing solutions that can quickly identify the causative agents of infections and guide appropriate treatment strategies. This growing awareness of the impact of HAIs on patient outcomes and healthcare costs is propelling the market forward.

Technological advancements in diagnostic testing are revolutionizing the hospital-acquired disease testing market. Innovations such as molecular diagnostics, point-of-care testing, and next-generation sequencing are enhancing the speed and accuracy of pathogen detection. These technologies enable healthcare providers to implement timely interventions, reducing the duration of hospital stays and improving overall patient outcomes. Additionally, the integration of digital health solutions, including electronic health records and laboratory information systems, is streamlining data management and facilitating better communication among healthcare teams, further enhancing the efficiency of infection control measures.

Moreover, the hospital-acquired disease testing market will benefit from increased regulatory scrutiny and public health initiatives aimed at reducing HAIs. As healthcare organizations adopt stringent infection prevention protocols, the demand for comprehensive testing solutions will rise. Collaborative efforts between diagnostic companies, healthcare providers, and regulatory bodies will be essential in developing standardized testing guidelines and ensuring the widespread adoption of best practices. As the market evolves, the focus will shift towards integrating testing into broader infection control strategies, emphasizing the importance of surveillance, early detection, and targeted interventions in combating hospital-acquired diseases.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Test Type

  • Urinary Tract Infection
  • Surgical Site Infection
  • Pneumonia Stents
  • Blood Stream Infection
  • Methicillin-Resistant Staphylococcus Aureus
  • Others

By End User

  • Hospitals and Intensive Care Units (ICUS)
  • Ambulatory Surgical and Diagnostic Centers
  • Nursing Homes and Maternity Centers
  • Companies
  • COMPANIES PROFILED
  • Abbott
  • Eurofins Scientific
  • BIOMERIEUX
  • Cantel Medical
  • Meridian Bioscience Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • BD
  • Hologic Inc.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • Medtronic
  • Getinge AB
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE

  • 5.1. Overview By Test Type
  • 5.2. Historical and Forecast Data Analysis By Test Type
  • 5.3. Urinary Tract Infection Historic and Forecast Sales By Regions
  • 5.4. Surgical Site Infection Historic and Forecast Sales By Regions
  • 5.5. Pneumonia Stents Historic and Forecast Sales By Regions
  • 5.6. Blood Stream Infection Historic and Forecast Sales By Regions
  • 5.7. Methicillin-Resistant Staphylococcus Aureus Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY END USER

  • 6.1. Overview By End User
  • 6.2. Historical and Forecast Data Analysis By End User
  • 6.3. Hospitals and Intensive Care Units (ICUS) Historic and Forecast Sales By Regions
  • 6.4. Ambulatory Surgical and Diagnostic Centers Historic and Forecast Sales By Regions
  • 6.5. Nursing Homes and Maternity Centers Historic and Forecast Sales By Regions
  • 6.6. Companies Historic and Forecast Sales By Regions

7. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES

  • 8.1. Hospital Acquired Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Eurofins Scientific
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. BIOMÉRIEUX
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Cantel Medical
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Meridian Bioscience Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. QIAGEN
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. F. Hoffmann-La Roche Ltd
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. BD
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Hologic Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Siemens Healthcare Private Limited
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Thermo Fisher Scientific Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Medtronic
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Getinge AB
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Test Type (Units and USD MN)
  • Urinary Tract Infection Market Sales By Geography (Units and USD MN)
  • Surgical Site Infection Market Sales By Geography (Units and USD MN)
  • Pneumonia Stents Market Sales By Geography (Units and USD MN)
  • Blood Stream Infection Market Sales By Geography (Units and USD MN)
  • Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By End User (Units and USD MN)
  • Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
  • Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
  • Companies Market Sales By Geography (Units and USD MN)
  • Global Hospital Acquired Disease Testing Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hospital Acquired Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Hospital Acquired Disease Testing Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Test Type (Units and USD MN)
  • Urinary Tract Infection Market Sales By Geography (Units and USD MN)
  • Surgical Site Infection Market Sales By Geography (Units and USD MN)
  • Pneumonia Stents Market Sales By Geography (Units and USD MN)
  • Blood Stream Infection Market Sales By Geography (Units and USD MN)
  • Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By End User (Units and USD MN)
  • Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
  • Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
  • Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
  • Companies Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.